Baumgartner R A, Deramo V A, Beaven M A
Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
J Immunol. 1996 Nov 1;157(9):4087-93.
We found that production and release of two functionally antagonistic cytokines, TGF-beta and TNF-alpha, were regulated differently in the mast cell, T cell, and macrophage cell lines RBL-2H3, MLA-144, and U-937, respectively. TGF-beta was produced and released constitutively in all three cell lines. When, however, the cell lines were stimulated with Ag, LPS, or calcium ionophore plus PMA, acceleration of release and some additional production of TGF-beta were apparent. In contrast, TNF-alpha was produced and released only when these lines were stimulated. Although neither the glucocorticoid, dexamethasone, nor the protein kinase C inhibitor, Ro31-7549, suppressed constitutive production or release of TGF-beta, these agents inhibited TNF-alpha production and the inducible component of TGF-beta production noted above. The release of these cytokines, whether constitutive or inducible, was dependent on Golgi-processing as indicated by inhibition with brefeldin A. Therefore, although both types of cytokines were processed by Golgi, only TNF-alpha and the inducible component of TGF-beta production were protein kinase C or steroid-regulated processes. These findings suggested that constitutive and inducible pathways exist for production and release of cytokines and that the inducible pathways can be selectively suppressed by pharmacologic agents.
我们发现,两种功能上相互拮抗的细胞因子,即转化生长因子-β(TGF-β)和肿瘤坏死因子-α(TNF-α),在肥大细胞系RBL-2H3、T细胞系MLA-144和巨噬细胞系U-937中的产生和释放受到不同的调节。在所有这三种细胞系中,TGF-β都是组成性产生和释放的。然而,当用抗原(Ag)、脂多糖(LPS)或钙离子载体加佛波酯(PMA)刺激这些细胞系时,TGF-β的释放加速且有一些额外的产生。相反,TNF-α仅在这些细胞系受到刺激时才产生和释放。尽管糖皮质激素地塞米松和蛋白激酶C抑制剂Ro31-7549都不能抑制TGF-β的组成性产生或释放,但这些药物能抑制TNF-α的产生以及上述TGF-β产生的诱导成分。如用布雷菲德菌素A抑制所表明的,这些细胞因子的释放,无论是组成性的还是诱导性的,都依赖于高尔基体加工。因此,尽管这两种类型的细胞因子都由高尔基体加工,但只有TNF-α和TGF-β产生的诱导成分是蛋白激酶C或类固醇调节的过程。这些发现表明,细胞因子的产生和释放存在组成性和诱导性途径,并且诱导性途径可被药物选择性抑制。